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ABSTRACT
Disruption of CTCF/cohesin-mediated 
high-order chromatin structures 
by DNA methylation downregulates 
PTGS2 expression
Jee-Youn Kang
Department of Molecular Medicine 
and Biopharmaceutical Sciences 
World Class University Graduate School 
of Convergence Science and Technology
Seoul National University 
The CCCTC-binding factor (CTCF)/cohesin complex regulates gene 
ii
transcription via high-order chromatin organization of the genome. De novo 
methylation of CpG islands in the promoter regions is an epigenetic 
hallmark of gene silencing in cancer. Although the CTCF/cohesin complex 
preferentially targets hypomethylated DNA, it remains unclear if 
CTCF/cohesin-mediated high-order chromatin structure is affected by DNA 
methylation during tumorigenesis. We found that DNA methylation 
down-regulates expression of prostaglandin-endoperoxidesynthase 2 (PTGS2), 
which is an inducible, rate-limiting enzyme for prostaglandin synthesis, by 
disrupting CTCF/cohesin-mediated chromatin looping. We show that the 
CTCF/cohesin complex is enriched near a CpG island associated with 
PTGS2. The PTGS2 locus forms chromatin loops through 
methylation-sensitive binding of the CTCF/cohesin complex. However, DNA 
methylation abolishes the association of the CTCF/cohesin complex with the 
PTGS2 CpG island. Disruption of chromatin looping by DNA methylation 
abrogates the enrichment of transcriptional components, such as positive 
elongation factor b, at the transcriptional start site of the PTGS2 locus. 
These alterations result in the down-regulation of PTGS2. Our results 
provide evidence that CTCF/cohesin-mediated chromatin looping of the 
PTGS2 locus is dynamically influenced by the DNA methylation status.
 
Keywords: DNA methylation; PTGS2; CTCF; cohesin; high-order chromatin 
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INTRODUCTION
Genomes are dynamically packaged into a compact three-dimensional 
nuclear space to form high-order chromatin structures. This packaging occurs 
in a highly specific manner to facilitate nuclear functions, such as DNA 
replication, DNA repair, and transcription.7, 25, 29, 36 Many high-order 
chromatin structures are established by a special class of architectural 
proteins, of which CCCTC-binding factor (CTCF) and cohesin are the best 
characterized.27 CTCF forms long-range chromatin interactions between 
enhancers and promoters.21 Half of the cohesin molecule colocalizes to the 
same regions with the CTCF-binding sites in the mammalian genome and 
prior studies have shown that CTCF is required for the recruitment of 
cohesin to these binding sites.9, 28, 34 Apart from its major function in sister 
chromatid cohesion,10 cohesin affects gene transcription by facilitating 
long-range chromatin interactions along with CTCF between the members of 
many developmentally regulated gene families.35, 37, 46
  Epigenetic modification is a heritable change in gene expression 
without alterations in DNA sequence and is a hallmark of cancer.2, 27 DNA 
methylation of CpG islands in promoter regions is a predominant epigenetic 
mechanism by which various genes are inactivated during tumorigenesis.17 
CTCF is associated with the transcriptional regulation of several imprinted 
genes, such as the IGF2/H19 locus, by preferentially targeting 
hypomethylated DNA.3, 18, 33 Thus, aberrant de novo DNA methylation may 
prevent the binding of CTCF to the promoter region, facilitating 
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transcriptional silencing of the gene. Although genes that may be influenced 
by this type of regulation have been proposed,1, 4, 19, 26 there is no direct 
evidence that CTCF/cohesin-mediated long-range chromatin interactions are 
disrupted by DNA methylation during tumorigenesis.
Prostaglandin-endoperoxidesynthase 2 (PTGS2, also known as 
cyclooxygenase-2 or prostaglandin G/H synthase 2) is the inducible form of 
the rate-limiting enzyme for prostaglandin production.36 An aberrantly high 
level of PTGS2 expression is frequently detected in numerous cancers and 
other diseases.36 Conversely, we and others have reported that 
hypermethylation of the PTGS2 CpG island directly down-regulates PTGS2 
expression in many human cancers, including gastric and colorectal 
cancers.30, 35 Considering that gastric cancers with PTGS2 CpG island 
methylation show significantly lower recurrence and improved overall 
survival,6 it is important to understand the underlying mechanisms leading to 
transcriptional silencing of PTGS2 by DNA methylation.
In the present investigation, we examined if DNA methylation can 
down-regulate PTGS2 expression by disrupting CTCF/cohesin-mediated 
chromatin looping of the PTGS2 locus. Our data show that enrichment of 
the CTCF/cohesin complex near the PTGS2 CpG island is prohibited by 
DNA methylation. Reduced CTCF/cohesin binding abolishes the spatial 
proximity between CTCF/cohesin binding sites. As a result, the recruitment 
of key transcriptional components, such as positive elongation factor b 
(P-TEFb), are diminished, leading to decreased transcriptional elongation and 
a low level of PTGS2 expression. Our findings strongly suggest that DNA 
methylation down-regulates PTGS2 expression by disrupting 
3





Cells were obtained from American Tissue Culture Collection or the 
Korean Cell Line Bank and were not cultured for longer than six months. 
Cells were cultured in DMEM or RPMI 1640 supplemented with 10% fetal 
bovine serum and gentamicin (10μg/mL) at 37 °C in a 5% CO2-humidified 
atmosphere. 
Virus production, and transduction
Control GFP and RAD21-directed TRC lentiviral shRNAs (#35 and 
#98) were purchased from Open Biosystems. Lentiviruses were produced by 
transducing 293FT cells with shRNA using a Virapower packaging mix 
(Invitrogen) as previously described.31 Briefly, the viruses were harvested 
from media on day 3 by centrifugation, and cells were incubated with viral 
supernatant in the presence of 6 μg/mL polybrene (Sigma). After two days 
of incubation, transduced cells were cultured in the presence of 1 μg/mL 
puromycin(Sigma) for another three days before collection as previously 
described.16 Silencing was confirmed by western blot analysis and qPCR. 
Flow cytometry was performed as previously described.16
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Bisulfite Sequencing and Pyrosequencing
Genomic DNA (gDNA) samples were isolated using a QIAamp 
DNA mini kit (Qiagen). gDNA (1 μg) was treated with sodium bisulfite and 
EpiTech Bisulfite (Qiagen). For bisulfite sequencing, PCR was performed as 
follows: 95 °C for 10 min, 32 cycles of 95 °C for 20s, 56 °C for 20s, 72 °C 
for 20s, followed by a final extension at 72 °C for 10 min. The PCR 
products were gel purified and cloned into a TOPO TA cloning vector 
(Invitrogen). The inserted PCR fragments of individual clones were 
sequenced. For pyrosequencing analysis, bisulfite-modified gDNA was 
amplified with specific primers that were biotinylated. Preparation of 
single-stranded DNA template, annealing to the pyrosequencing primer, and 
pyrosequencing were performed using Pyro Gold Q96 SQA reagents with a 
PyroMark ID pyrosequencer (Qiagen) according to the manufacturer's 
protocol. The pyrosequencing data were analyzed using Pyro Q-CpG 
software (Qiagen). All primer sequences for PCR and pyrosequencing are 
available upon request.
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Reverse transcription and quantitative real-time PCR 
(qRT-PCR)
Total RNA was prepared using the TRI Reagent (Molecular 
Research Center) in accordance with the manufacturer’s instructions. Briefly, 
total RNA (2 μg) was reverse transcribed using ImProm-II reverse 
transcriptase (Promega) and random hexamers as previously described.30, 31 
For quantitative real-time PCR (qRT-PCR), cDNAs were amplified with 
SYBR Green (Molecular Probes) using StepOnePlus (Applied Biosystems) as 
previously described.16
Table 1. Primer sequences for quantitative real time PCR
GENE SEQUENCE (5' -> 3')
PTGS2
F    TGAGCATCTACGGTTTGCTG
R    TGCTTGTCTGGAACAACTGC
Rad21
F    TGACTTTGATCAGCCACTGC
R    TCTCACGATCATCCATTCCA
CTCF
F    TTACACGTGTCCACGGCGTTC
R    GCTTGTATGTGTCCCTGCTGGCA
7
Chromatin immunoprecipitation (ChIP) assay 
ChIP assays were performed as previously described.31, 46 Briefly, 
cells were cross-linked with 1% formaldehyde for 10min at room 
temperature. 0.125M glycine was added for 5min at room temperature to 
terminate the reaction. Nuclei were prepared and digested with 50 U MNase 
at 37°C for 15 min, and then were sonicated to yield chromatin fragments 
of 200–400 bp. The precleared chromatin was overnight incubated with 
antibodies at 4°C. The chromatin was incubated with protein A agarose 
(Millipore), which was pre-equilibrated with sonicated salmon sperm DNA 
and BSA. Immunoprecipitated material was then washed extensively, and the 
crosslinks were reversed. DNA from eluted chromatin was purified by 
phenol extraction and ethanol precipitation. qPCR using SYBR Green 
(Molecular Probes) was performed to observe enriched DNA The enrichment 
of target DNA over the input was calculated using the ΔΔCt method ,and 
the results were presented as the mean ± SEM.16, 31
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Table 1. Primer sequences for quantitative real time PCR
GENE SEQUENCE (5' -> 3')
PTGS2_1
F   ATGAAACAACCAGCCAAACC
R   CTCCCCCTAGAGGTTGGAGT
PTGS2_2
F    TGCTGGTCATGGGAGTGTAT
R   TTTCCCAACAAATTTCAGACG
PTGS2_3
F   TGTTCTCCGTACCTTCACCC
R   CCGCTTCCTTTGTCCATCAG
PTGS2_4
F   TAGGCTTTGCTGTCTGAGGG
R   ATTTCGTCACATGGGCTTGG
PTGS2_5
F   GTTCCCACCCATGTCAAAAC
R   AAAATTCCGCTGCAAGAAGA
PTGS2_6
F   TGAGCATCTACGGTTTGCTG
R   TGCTTGTCTGGAACAACTGC
PTGS2_7
F   GATTTGAGAGCCCACACCAT
R   CATGCAAACCACACAGAACC
Necdin
F    CTGGAGGCAGATGAATGGTT
R   GGTAGCACAAAAGCGAAAGC
P21(+1775)
F   AGCCGGAGTGGAAGCAGA
R    AGTGATGAGTCAGTTTCCTGCAAG
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Chromosome conformation capture (3C) assay
A 3C assay was performed as previously described7, 34 with minor 
modification. Briefly, chromatin cross-linked in 1% formaldehyde was 
digested with 500 U EcoRI (NEB) overnight followed by ligation with 
2,000 U of T4 DNA ligase (NEB) at 16°C for 4 h. Cross-linking was 
reversed, and DNA was purified by phenol extraction and ethanol 
precipitation as previously described.31 To generate control templates as 
positive controls, the BAC clone CTD-3241P15, which covered the entire 
PTGS2 locus, was digested with 200 U EcoRI overnight at 37°C as 
previously described.32 After phenol extraction and ethanol precipitation, 
DNA fragments (200 ng/μL) were ligated with T4 DNA ligase. Digestion 
efficiency was calculated as previously described,14 and samples with 
efficiencies >90% were used for 3C assays. Cross-linking frequency and 
ligation efficiencies between different samples were normalized relative to 
the ligation frequency of two adjacent digested fragments in the CalR 
gene.34 Quantification of the data was performed by qPCR using SYBR 
Green (Molecular Probe). EcoRI restriction sites in the PTGS2 locus appear 
as gray, shaded bars. Black shading indicates the anchor fragment of the 
transcriptional start site of PTGS2. The maximum cross-linking frequency 




Antibodies specific for the following were used in this study: 
PTGS2 (SC-1745), normal rabbit IgG (SC-2027), CDK9 (SC-484), and RNA 
pol II (SC-899) was purchased from Santa Cruz Biotechnology; Ser2P Pol II 
(ab5059), H3K4me1 (ab8895), and RAD21 (ab992) were from AbCam, and 
AcH3 (06-599), CTCF (07-729), H3K4me3 (07-473), and H3K27me2 
(07-452) were from Millipore. Anti-SMC1 antibody (A300-055A) was 
purchased from Bethyl Laboratories. 
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RESULTS 
1. The PTGS2 locus forms spatial chromatin organization in 
a methylation-sensitive manner
A bioinformatics search of the UCSC Genome database 
(http://genome.ucsc.edu/) for CTCF/cohesin binding motifs across the PTGS2 
locus revealed four putative candidate sites (Figure 1a). One of the 
CTCF/cohesin-binding motifs was located at the transcriptional start site in 
the PTGS2 CpG island (amplicons 3 and 4); thus, we speculated that the 
binding of CTCF/cohesin to the PTGS2 locus may be influenced by DNA 
methylation.
To test this hypothesis, we performed chromatin immunoprecipitation 
(ChIP) assays using two gastric cancer cells with different DNA methylation  
patterns at the PTGS2 CpG island. We previously showed that SNU668 
cells express a high level of PTGS2 and are devoid of DNA methylation at 
the PTGS2 CpG island. In contrast, SNU601 cells have undetectable PTGS2 
expression and are hypermethylated at the same region (Figures 1b-d).30 
High-resolution ChIP assays showed that CTCF binding occurred at four 
potential CTCF/cohesin binding sites in the PTGS2 locus in SNU668 cells 
with an unmethylated PTGS2 CpG island (black bars; amplicons 1, 2, 4, 
and 7) (Figure 1e). Prominent binding of RAD21, a core subunit of the 
cohesin complex,8 colocalized with CTCF at the PTGS2 locus in SNU668 
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cells (Figure 1f). However, despite similar binding patterns at most putative 
CTCF/cohesin-binding sites in the PTGS2 locus, recruitment of CTCF and 
RAD21 near the transcriptional start site of the PTGS2 locus in SNU601 
cells (red bars; amplicons 3, 4, and 5) was significantly less than that of 
SNU668 cells (Figures 1e and f). This difference in recruitment suggests 
that hypermethylation of the PTGS2 CpG island disrupted the binding of 
methylation-sensitive CTCF/cohesin at these sites in SNU601 cells. 
Consistent with active transcription of PTGS2 in SNU668 cells (Figures 1b 
and c), the binding of CTCF and cohesin at the transcriptional start site in 
the PTGS2 CpG island coincided with the enrichment of the active histone 
marker, H3K4 tri-methylation (H3K4me3)27 (Figure 1g). Repressive histone 
H3K27 di-methylation (H3K27me2)27 was enriched in SNU601 cells with a 
methylated PTGS2 CpG island (Figure 1h). Similarly, CTCF/cohesin-binding 
sites were strongly enriched for histone H3K4 mono-methylation (H3K4me1), 
which is apredictive marker of enhancers,15 in SNU668 cells (Figure 1i). 
These data demonstrate that the CTCF/cohesin complex is localized at the 
CTCF/cohesin-binding sites of the PTGS2 locus in SNU668 cells express a 
high level of PTGS2. However, hypermethylation of the PTGS2 CpG island 
disrupts the binding of the methylation-sensitive CTCF/cohesin complex on 
these sites in SNU601 cells with methylated PTGS2.
Recent evidence indicates that CTCF and cohesin mediate 
long-range chromatin interactions at CTCF/cohesin-binding sites at the IFNG, 
IGF2-H19, and β-globin loci.13, 16, 21 To test whether the PTGS2 locus can 
form long-range chromatin interactions through CTCF/cohesin-binding, we 
performed chromosome conformation capture (3C) assays7 with the EcoRI 
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restriction enzyme to assess chromatin interactions across the PTGS2 locus 
(Figure 1j). The transcriptional start site of the PTGS2 locus strongly 
interacted with the CTCF/cohesin-binding sites at −42.5 kb and +74.5 kb in 
SNU668 cells, which display a high level of PTGS2 expression (black line, 
Figure 1j); no interactions were detected at other sites without CTCF/cohesin 
enrichment. The physical proximity of CTCF/cohesin-binding sites in 
SNU601 cells (red line, Figure 1j) was significantly lower than that of 
SNU668 cells. Thus, CTCF/cohesin may form long-range chromatin 
interactions at the PTGS2 locus to facilitate transcription and a high level of 
PTGS2 expression in SNU668 cells. In contrast, DNA methylation of the 
PTGS2 CpG island in SNU601 cells may abolish CTCF/cohesin-mediated 
spatial organization, resulting in transcriptional inefficiency.
We also compared the methylation status, CTCF/cohesin binding, 
and spatial chromatin organization of the PTGS2 locus in A549 and 
SNU719 cells. The A549 cells exhibits a methylation pattern similar to that 
of SNU668 cell, whereas, SNU719 cells demonstrate a methylation pattern 
similar to that of SNU601 cells. As expected, our results in A549 and 
SNU719 cells were similar to the previous results obtained from SNU668 
and SNU601 cells. These data suggest that the inhibitory effect of DNA 
methylation on CTCF/cohesin-mediated high-order chromatin structures at the 
PTGS2 locus may be generalized to other cell lines.
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Figure 1. The spatial chromatin organization of the PTGS2 locus by 
methylation-sensitive binding of CTCF/cohesin. (a) The PTGS2 locus at 
chromosome 1q31.1 is illustrated to scale. The location of putative 
CTCF/cohesin-binding sites and the primer pairs used for quantitative 
real-time PCR (qPCR) are shown with labels below. The PTGS2 CpG island 
is also shown. Exon1 is indicated by a gray box. Vertical bars represent 
each CpG site. TSS, transcriptional start site. (b) PTGS2 mRNA expression 
in SNU668 and SNU601 cells was analyzed by qRT-PCR and normalized 
relative to 18S ribosomal RNA. Data are presented as the mean ± SD of 
triplicate independent RNA preparations. *P<0.05, **P<0.001.  (c) Western 
blot analysis was performed with anti-PTGS2 antibody; a-tubulin served as a 
loading control. (d) Bisulfite sequencing analysis of the PTGS2 CpG island 
in SNU668 and SNU601 cells is shown. Each square denotes a CpG site 
within the PCR product amplified from bisulfite-treated DNA.38 (Filled 
squares: methylated; open squares: unmethylated).
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Figure 1. (e-i) A ChIP assay was performed with SNU668 (black bars) or 
SNU601 (red bars) cells using antibodies against (e) CTCF, (f) RAD21, (g) 
H3K4me3, (h) H3K27me2, and (i) H3K4me1. qRT-PCR using SYBR Green 
was performed to detect enriched DNA. Enrichment of target DNA over 
input was calculated using the ΔΔCt method,16, 31 and results are represented 
as the mean ± SEM, n = 3. The +1775 site (amplicon 8) of the P21 
locus12 and NECDIN (amplicon 9)31 served as positive and negative controls, 
respectively, for CTCF/cohesin binding. 
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Figure 1. (j) Relative cross-linking frequencies among CTCF/cohesin-binding 
sites in the PTGS2 locus were measured with a 3C assay7 in SNU668 
(black line) and SNU601 (red line) cells. Chromatin cross-linked in 1% 
formaldehyde was digested with the restriction enzyme EcoRI overnight, 
followed by ligation with T4 DNA ligase at 16°C for 4h.16, 31, 34 
Cross-linking was reversed, and the DNA was purified as previously 
described.31 Cross-linking frequencies and ligation efficiencies between 
different samples were normalized relative to the ligation frequency of two 
adjacent digested fragments in the CalR gene.34 Quantification of data was 
performed by qPCR using SYBR Green. EcoRI restriction sites in the 
PTGS2 locus appear as gray, shaded bars. Black shading indicates the 
anchor fragment of the transcriptional start site of PTGS2. The maximum 
cross-linking frequency was set to 1 (mean ± SEM, n = 4).
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2. DNA methylation reduces the spatial organization of the 
PTGS2 locus
We examined whether DNA methylation abrogates transcription by 
disrupting the binding of CTCF/cohesin to the PTGS2 locus. We determined 
the dynamics of CTCF and cohesin binding after treatment of SNU601 cells 
with the demethylating agent, 5-Aza-2’-deoxycytidine (5-aza-CdR).38
Treatment with 5-aza-CdR caused a dose-dependent reactivation of 
PTGS2 mRNA expression in SNU601 cells (Figure 2a). Pyrosequencing 
analysis of SNU601 cells treated with 500 nM 5-aza-CdR demonstrated 
reduced DNA methylation at the PTGS2 CpG island (Figure 2b), confirming 
the importance of DNA methylation in the transcriptional repression of 
PTGS2.30 Next, ChIP assay with antibodies against CTCF and cohesin was 
performed on SNU601 cells treated with 500 nM 5-aza-CdR (Figures 2c and 
d). Demethylation of the PTGS2 CpG island by 5-aza-CdR treatment 
(Figures 2a and b) resulted in increased binding of CTCF and cohesin at 
the PTGS2 CpG island (red bars; amplicons 3, 4, and 5 in Figures 2c and 
d). Binding of CTCF and cohesin at this region was undetectable in 
DMSO-treated SNU601 cells (black bars; Figures 2c and d); thus, we 
concluded that CTCF and cohesin binding was influenced by the methylation 
status of the PTGS2 CpG island.
Because G9A- and EZH2-mediated histone modification cooperates 
with DNA methyltransferases to silence PTGS2 expression,5 we asked if 
5-aza-CdR treatment changed the epigenetic signatures within the PTGS2 
locus. Upon 5-aza-CdR treatment, the binding of active H3K4me3 within the 
PTGS2 locus was enhanced by approximately 10-fold (Figure 2e) in parallel 
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with increased transcription of PTGS2 (Figure 2a). Interestingly, the 
repressive H3K27me2 mark throughout the PTGS2 locus was also slightly 
enriched after 5-aza-CdR treatment (Figure 2f), consistent with the previous 
observation that promoter regions of demethylated genes are frequently 
marked by bivalent histone modifications in human cancer cells.9, 20 Taken 
together, the binding of CTCF and cohesin to their binding sites at the 
transcriptional start site of PTGS2 was regulated by DNA methylation within 
the PTGS2 CpG island.
Consistent with the increased enrichment of CTCF and cohesin 
(Figures 2c and d), the physical proximity of the PTGS2 locus in the 
5-aza-CdR treated SNU601 cells (red line, Figure 2g) was significantly 
increased compared to that in control DMSO-treated cells (black line, Figure 
2g). These results suggest that DNA methylation of the PTGS2 CpG island 




Figure 2. De-methylation of the PTGS2 CpG island restores the spatial 
organizatin of the PTGS2 locus. (a) SNU601 cells were treated with 500 
nM or 1mM 5-aza-CdR for 4 days, and PTGS2 mRNA levels were 
analyzed with qRT-PCR and normalized to 18S ribosomal RNA (mean ± 
SD, n = 4). *P<0.05,**P<0.001. (b) SNU601 cells were treated with 500 
nM or 1mM 5-aza-CdR for 4 days, followed by genomic DNA preparation. 
For pyrosequencing analysis,38 bisulfite-modified genomic DNA was 
amplified with specific biotinylated primers. Quantitative analysis of the 
PTGS2 CpG island methylation was performed using a PyroMark ID 
pyrosequencer (Qiagen) as previously described.38 Locations of sequences 
corresponding to the four primer sets used for pyrosequencing are indicated 
by arrows. The y-axis represents the percentage of CpG methylation of each 
sequence (mean ± SD, n= 3). *P<0.05, **P<0.001.
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Figure 2. (c-f) SNU601 cells were treated with DMSO (black bars) or 500 
nM 5-aza-CdR (red bars) for 4 days, and the ChIP assay was performed 
using antibodies against (c) CTCF, (d) RAD21, (e) H3K4me3, and (f) 
H3K27me2. qRT-PCR using SYBR Green was performed to detect enriched 
DNA. Enrichment of target DNA over input was calculated using the ΔΔCt 
method,16, 31 and results are represented as the mean ± SEM, n = 4. The 
+1775 site (amplicon 8) of the P21 locus12 and NECDIN (amplicon 9)31 
served as positive and negative controls, respectively, for CTCF/cohesin 
binding.
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Figure 2. (g) Relative cross-linking frequencies among CTCF/cohesin-binding 
sites in the PTGS2 locus were measured with a 3C assay7 in SNU601 cells 
after treatment with DMSO (black line) or 500 nM 5-aza-CdR (redline) for 
4 days. EcoRI restriction sites in the PTGS2 locus appear as gray, shaded 
bars. Black shading indicates the anchor fragment of the transcriptional start 
site of PTGS2. The maximum cross-linking frequency was set to 1 (mean ± 
SEM, n = 5).
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 3. Cohesin binding is crucial for the spatial organization of 
the PTGS2 locus
To test if CTCF/cohesin binding is a prerequisite for efficient 
transcription of PTGS2, we reduced the expression of cohesin using RAD21 
knockdown (KD) in SNU668 cells. Two different RAD21-specific shRNAs 
reduced RAD21 expression with a similar efficiency, decreasing RAD21 
mRNA and protein levels by approximately 90% in SNU668 cells (Figures 
3a and d). Using fluorescence-activated cell sorting (FACS) analysis we 
observed that RAD21-KD SNU668 cells exited mitosis, divided, and survived 
well without pronounced levels of cell death (Figure 3e), which is consistent 
with earlier data.22, 29 Notably, PTGS2 mRNA and protein expression were 
significantly reduced by RAD21-KD in SNU668 cells (Figures 3b and c). 
We obtained similar results after RAD21-KD in A549, HeLa, and N87 
cancer cells, which have high levels of PTGS2 expression (Figure 3f). 
Furthermore, although PTGS2 expression was induced by phorbol12-myristate 
13-acetate (PMA) treatment in control SNU668 cells,11 we found that 
PMA-induced PTGS2 expression was completely abrogated in RAD21-KD 
SNU668 cells (Figure 3g); these data suggest that cohesin is crucial for 
optimal expression of PTGS2 in human cancer cells.
Next, we determined if cohesin is essential for long-range chromatin 
interactions (Figure 1j). Our ChIP experiments showed that RAD21-KD 
resulted in a two-fold reduction in the prominent binding between RAD21 
and Structural Maintenance of Chromosomes 1 (SMC1), two members of the 
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cohesin complex,8 at the PTGS2 locus (Figure 3h). These results suggest 
that RAD21-KD blocks the formation and enrichment of the cohesin 
complex at the PTGS2 locus in SNU668 cells. However, RAD21-KD had no 
significant effect on the expression or binding of CTCF at the PTGS2 locus 
(Figure 3h); this finding supports the paradigm that CTCF binds to 
chromatin independently of cohesin.23, 37 Using the 3C assay with 
RAD21-KD SNU668 cells, we found that the spatial proximity in the 
RAD21-KD SNU668 cells (red line, Figure 3i) was significantly lower 
(two-fold) than that in the control GFP-KD SNU668 cells (black line, 
Figure 3i). We also identified that re-establishment of CTCF/cohesin 
mediated high-order chromatin structures after the 5-aza-CdR treatment was 
significantly abolished after Rad21 knockdown (Figure 4). Consequently, 
re-expression of PTGS2 mRNA after the 5-aza-CdR treatment was also 
abrogated (Figure 4). These data argue that cohesin binding is required for 
the long-range chromatin interactions among CTCF/cohesin-binding sites in 
the PTGS2 locus.
Next, we examined how cohesin-mediated spatial chromatin 
organization affects PTGS2 expression. We examined enrichment of the 
elongation-competent form of RNA pol II (Pol II), which is phosphorylated 
at Ser2 of the C-terminal domain (Ser2P), in RAD21-KD SNU668 cells.10 
The binding of Ser2P Pol II was significantly decreased throughout the 
coding region of the PTGS2 locus in RAD21-KD SNU668 cells (Figure 3h), 
which was consistent with the reduced expression of PTGS2 (Figure 3b). 
We found that CDK9, a subunit of the P-TEFb complex that catalyzes 
phosphorylation of Ser2P,10 was also reduced at these sites by approximately 
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two-fold in RAD21-KD SNU668 cells (Figure 3h). These data confirm 
previous observations that cohesin facilitates the transition of paused Pol II 
to elongation.29 In addition, the binding of acetylated histone H3 (AcH3), a 
marker of active transcription,27 was present within the PTGS2 locus, 
although it was reduced by two-fold at these sites in the RAD21-KD 
SNU668  cells (Figure 3h).
Together, these results suggest that cohesin-mediated spatial 
chromatin organization of the PTGS2 locus is required for recruitment of the 
transcription regulator P-TEFb to enhance elongation of PTGS2 transcripts.
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Figure 3. Cohesin depletion reduces PTGS2 expression by abolishing proper 
spatial chromatin organization of the PTGS2 locus. SNU668 cells were 
transduced with control (GFP) shRNA or two different RAD21 shRNAs 
(#35 and #98) for five days. Lentiviruses were produced as previously 
described.31 (a) RAD21and (b) PTGS2 mRNA expression levels were 
analyzed with qRT-PCR and normalized to that of 18S ribosomal RNA 
relative to control GFP-shRNA-expressing cells. (c) CTCF mRNA expression 
was also analyzed to show RAD21 knockdown does not affect CTCF 
mRNA expression. Data are the mean ± SD of triplicate independent viral 
transduction experiments.*P<0.05, **P<0.001. (d) Western blot analysis was 
performed with anti-RAD21 and anti-PTGS2 antibodies on day 5 after 
RAD21-KD; α-tubulin served as a loading control.
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Figure 3. (e) Cells were stained with propidium iodide on day 5 after 
RAD21-KD and subjected to FACS analysis. A representative image of the 
percentage of cells in the G0, G1, S, and G2/M phases is shown.
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Figure 3. (f) Down-regulation of cohesin by RAD21-KD reduced PTGS2 
expression in A549, Hela, and N87 cells. A549 (upper panels), HeLa 
(middle panels), and N87 (lower panels) cells were transduced with GFP or 
two different RAD21 shRNAs (#35 and #98) for 5 days. RAD21 and PTGS2 
mRNA expression levels were analyzed with qRT-PCR and normalized to 
that of 18S ribosomal RNA relative to the GFP shRNA-expressing cells. 
Data are expressed as the mean ± SD of triplicate independent viral 
transduction experiments. Western blot analysis was performed on A549, 
HeLa, and N87 cell extracts with RAD21 and PTGS2 antibodies on day 5 
after RAD21-KD with a-tubulin serving as a loading control.
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Figure 3. (g) PMA-mediated PTGS2 mRNA induction was inhibited by 
reduction of cohesin expression in SNU668 and A549 cells. SNU668 and 
A549 cells were transduced with control GFP or RAD21 shRNA (#35). On 
day 5 after RAD21-KD, cells were treated with 100ng/ml phorbol 
12-myristate 13-acetate (PMA, Sigma) or DMSO for 24 h. RAD21 and  
PTGS2 mRNA expression levels were analyzed with qRT-PCR and 
normalized to 18S ribosomal RNA. Data are the mean ± SD of triplicate 




Figure 3. (h) A ChIP assay was performed with GFP-KD (black bars) or 
RAD21-KD SNU668 (#35; red bars) cells on day 5 after RAD21-KD using 
antibodies against RAD21, SMC1, CTCF, Ser2P, CDK9, and AcH3 (mean ± 
SEM, n = 3).
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Figure 3. (i) Long-range interactions at the PTGS2 locus were assessed with 
a 3C assay using GFP-KD (black line) or RAD21-KD SNU668 (red line) 
cells. EcoRI restriction sites in the PTGS2 locus appear as gray, shaded 
bars. Black shading indicates the anchor fragment of the transcriptional start 
site of PTGS2. The maximum cross-linking frequency was set to 1 (mean ± 




Figure 4. 5-aza-CdR mediated PTGS2 mRNA induction was reduced by 
knockdown of cohesin expression in SNU601 cells. SNU601 cells were 
transduced with control GFP or RAD21 shRNA (#35). On day 5 after 
RAD21-KD, cells were treated with DMSO or 500nM 5-aza-CdR for 4 days. 
(a) RAD21 and (b) PTGS2 mRNA expression levels were analyzed with 
qRT-PCR and normalized to 18S ribosomal RNA relative to the 
GFP-shRNA expressing cells. Data are the mean ± SD of triplicate 
independent viral transduction experiments. (c) Bisulfite-treated gDNA was 
used to determine the methylation ratio of the PTGS2 CpG island by 
pyrosequencing (mean ± SD, n = 3). (d) Long-range interactions at the 
PTGS2 locus were assessed with a 3C assay using GFP or RAD21-KD 
(R#35) SNU601 cells after treatment with DMSO or 500nM 5-aza-CdR for 
4 days (mean ± SEM, n = 3).
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DISCUSSION
Cohesin-mediated chromatin looping is essential for PTGS2 
expression
In the present investigation, we found that CTCF/cohesin-mediated 
spatial chromatin organization is an essential mechanism for transcriptional 
regulation of PTGS2 (Figure 5). Deregulation of CTCF/cohesin binding by 
DNA methylation may disrupt the proper spatial chromatin organization of 
the PTGS2 locus, which subsequently reduces overall PTGS2 expression. We 
found that down-regulation of cohesin abolished the proximity among the 
CTCF/cohesin-binding sites without disturbing CTCF enrichment in 
RAD21-KD cells (Figure 3i). CTCF positions cohesin at the cohesin-binding 
sites.23, 28 CTCF binds to the PTGS2 CpG island in a DNA 
methylation-sensitive manner (Figure 1e). Thus, we propose that DNA 
methylation abrogates spatial chromatin organization of the PTGS2 locus by 
disrupting both CTCF and cohesin binding, both of which are indispensable 
for direct interactions among CTCF/cohesin-binding sites. Considering the 
recent discovery that aberrant overexpression of the cohesin component is 
frequently detected in many human cancers,24 this raises the possibility that 
activated CTCF/cohesin mediates PTGS2 up-regulation, which is associated 
with tumor progression. Thus, hypomethylation of PTGS2 may confer an 
obvious advantage to cancer cells by increasing and maintaining elevated 
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levels of PTGS2 during tumor development.25
Our results provide evidence that cohesin-mediated spatial chromatin 
organization can be abolished by DNA methylation at the PTGS2 CpG 
island; this finding highlights a mechanistic linkage between high-order 
chromatin structures and DNA methylation during tumorigenesis. Our 
findings correlate with a previous result that gastric cancer patients with 
methylated PTGS2 show lower recurrence and improved overall survival 
rates compared to those of patients with unmethylated PTGS2.6 Thus, future 
studies should be performed to determine the detailed mechanism by which 
DNA methylation affects this dynamic transition of the high-order chromatin 
landscape during tumor progression; such studies will ultimately allow new, 




Figure 5. Cohesin is required for the formation of organized chromatin at 
the PTGS2 locus. A proposed model for stabilizing high-level PTGS2 
expression by cohesin-mediated chromatin looping is shown. The PTGS2 
locus forms chromatin loops in cancer cells that express high levels of 
PTGS2 (left). CTCF/cohesin (blue ovals) stabilizes long-range chromatin 
interactions through direct interactions at CTCF/cohesin localization sites. 
DNA methylation of the PTGS2 CpG island abolishes the association among 
CTCF/cohesin-binding sites at the PTGS2 locus by inhibiting the enrichment 
of CTCF/cohesin at these regions (right, grey oval). Deregulation of 
chromatin organization at the PTGS2 locus decreases the association of the 
transcription regulator P-TEFb near these regions, reducing PTGS2 expression 
in cancer cells with heavily methylated CpG islands.
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세포 내의 유전체는 다양한 3차 구조를 형성하는 것으로 알려져 
있으며, 이러한 3차 구조는 다양한 유전자의 발현을 직접적으로 조절
할 수 있는 것으로 알려져 있다. CCCTC-binding factor로 알려진 
CTCF 단백질은 3차 구조를 형성하는데 있어 가장 잘 알려져 있는 구
조 단백질로, 이들은 cohesin 단백질과 complex를 형성하여 서로 멀리 
위치해 있는 유전자의 promoter와 enhancer를 가깝게 위치하게 함으
로써 유전자 발현을 조절하는 것으로 알려져 있다. 하지만 이러한 구
조 단백질에 의해 형성되는 유전체의 3차원적 구조가 암화 과정에 있
어서 어떠한 역할을 수행하는지에 대한 연구는 부족한 실정이다.
CTCF 단백질은 CTCF 단백질 결합 부위 가까이에 위치한 CpG 
site의 methylation여부에 따라서 결합이 조절되는 것으로 알려져 있
다. 따라서 암화 과정동안 암세포 특이적으로 나타나는 CpG island에
서의 de novo methylation은 CTCF/cohesin을 매개로 하는 유전체의 3
차 구조 형성에 있어 중요한 역할을 수행할 것으로 생각된다. 암화과
정동안 CpG island de novo methylation에 의해 다양한 유전자의 발현
이 저해되는 것으로 알려져 있으나, 이러한 에피지네틱 변이가 유전
자의 전사를 어떻게 직접적으로 조절하는지에 대한 연구는 부족하다. 
따라서 PTGS2라는 유전자를 대상으로 promoter CpG island de novo 
methylation에 의한 유전자 발현의 저해가 유전자 발현에 있어서 중요
한 역할을 하는 것으로 알려진 CTCF/cohesin을 매개로 하는 유전체의 
3차 구조 형성 변형에 의한 결과인지를 확인하고자 하였다.
PTGS2는 일부 위암세포주에서 promoter부위의 DNA methylation
에 의해 저해되어 있는 것으로 알려져 있으며, CpG island 주변으로 
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CTCF와 cohesin binding site가 존재한다. 이를 토대로 실험을 진행하
였으며, 실제로 PTGS2의 발현이 저해되어 있는 세포주 (SNU601)에
서는 promoter부위에 methylation이 되어있고, CTCF/cohesin의 
binding은 저해되어 있는 것을 확인하였다. 반대로 PTGS2의 발현이 
높은 세포주 (SNU668)의 경우 promoter부위의 methylation이 확인
되지 않고, CTCF/cohesin의 결합 역시 높게 나타나는 것을 확인하
였다. Chromosome conformation capture (3C) assay 기법을 이용
하여 이러한 CTCF/cohesin 결합의 차이는 해당 부위의 3차원적 구
조와도 상관관계가 있음을 확인였다, 다시 말해, PTGS2의 발현이 높
고 CTCF/cohesin결합이 많은 것으로 확인된 세포주 (SNU668)의 경
우, 각각의 CTCF/cohesin결합 부위간의 거리가 그렇지 않은 세포주 
(SNU601)보다 가까이 위치함을 확인하였다. 뿐만 아니라 
demethylating agent로 알려진 5-Aza-CdR을 처리하여 SNU601에
서 DNA methylation을 저해시킬 경우, promoter 부위의 DNA 
methylation이 감소하면서 유전자의 발현이 증가할 뿐만 아니라 해당 
부위의 CTCF/cohesin의 binding 역시도 증가하는 것을 확인하였다. 
이러한 CTCF/cohesin의 binding의 증가는 CTCF/cohesin 결합 부위
간의 거리도 가깝게 만드는 것을 확인하였고, 이를 통해 DNA 
methylation이 CTCF/Cohesin 단백질의 결합을 조절할 수 있음을 증
명하였고 이러한 결합 조절이 결과적으로는 유전체의 3차원적 구조를 
조절하여 유전자 발현에 영향을 주는 것을 확인하였다. 마지막으로 
SNU668에서 cohesin을 구성하는 단백질 중 하나인 Rad21을 저해시
킴으로써, cohesin이 실제로 유전자의 발현과 PTGS2의 3차 구조를 
직접적으로 조절할 수 있는지 확인하였다. 그 결과 Rad21 
knockdown은 PTGS2의 유전자 발현을 저해시킬 뿐만 아니라 해당 
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부위의 3차원적 구조 역시도 조절함을 확인하였고, 이러한 3차원적 
구조는 유전자 발현에 있어 중요한 역할을 수행하는 전사체가 해당 
유전자에 형성되는데 있어 중요한 역할을 수행함을 증명하였다.
위와 같은 결과들을 토대로, 암화 과정 중에 나타나는 de novo 
CpG island methylation에 의한 유전자 발현 저해의 한 매커니즘으로 
CTCF/cohesin을 매개로 하는 유전자의 3차원적 구조의 역할과 그 중
요성을 증명하였다.
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